Up to 500 Amgen employees based at the company’s Thousand Oaks facilities will be relocated to a new site in Tampa, Fla. and other sites, or be terminated, over the next 18 months as part of a new restructuring plan.
Johnson & Johnson’s Human Performance Institute has developed a Premier Executive Leadership program to help executives avoid burnout.
AstraZeneca has won approval for its lung cancer pill Tagrisso in China, a key market for the potential blockbuster medicine.
President Donald Trump suffered a stunning political setback in a Congress controlled by his own party when Republican leaders pulled legislation to overhaul the U.S. healthcare system, a major 2016 election campaign promise of the president and his allies.
The Republican-controlled U.S. House of Representatives cleared the way for a contentious debate on legislation to repeal Obamacare and replace it with a more limited federal healthcare insurance program.
Pfizer Inc. today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending that Trumenba (Meningococcal Group B Vaccine) be granted marketing authorization in the European Union for active immunization of individuals 10 years and older to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroup B (MenB).
A panel of the European Medicines Agency said it recommended granting marketing approval to Danish drugmaker Novo Nordisk’s hemophilia B drug.
Habit and red tape are not sufficient excuses for life sciences organizations to keep doing things the way they always have.
A federal judge dismissed two of the six counterclaims that Express Scripts raised in health insurer’s Anthem’s $15 billion lawsuit claiming it charged too much for drugs.
Eli Lilly and Co. said it would invest $850 million in its U.S. operations during 2017, and the drugmaker signaled it would be willing to spend more if the Trump administration were to overhaul tax laws.